Stock Track | Indivior Soars 5% as Stifel Boosts Price Target by 29%

Stock Track

Nov 04, 2025

Shares of Indivior PLC (INDV) are soaring in Monday's trading session, climbing 5.01% as investors react to a significant analyst upgrade. The pharmaceutical company, known for its focus on addiction treatment, is seeing heightened interest following a bullish stance from a major financial firm.

The catalyst for today's upward movement appears to be Stifel's decision to raise its target price for Indivior from $28 to $36, representing a substantial 29% increase. This upgraded outlook from a respected financial services company has sparked renewed confidence among investors, driving the stock's impressive intraday gains.

While the specific reasons behind Stifel's more optimistic view weren't immediately clear, such upgrades often reflect an analyst's belief in a company's improved growth prospects or competitive position. For Indivior, this could potentially signal positive expectations regarding its product pipeline, market expansion efforts, or financial performance. As always, investors are advised to conduct their own research and consider multiple factors when making investment decisions.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1194116399"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194116399\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194116399?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-04 00:10","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194116399","market":"nz","top_or_hot":-1,"title":"Stock Track | Indivior Soars 5% as Stifel Boosts Price Target by 29%","media":"Stock Track","content":"<p>Shares of Indivior PLC (INDV) are soaring in Monday's trading session, climbing 5.01% as investors react to a significant analyst upgrade. The pharmaceutical company, known for its focus on addiction treatment, is seeing heightened interest following a bullish stance from a major financial firm.</p>\n\n<p>The catalyst for today's upward movement appears to be Stifel's decision to raise its target price for Indivior from $28 to $36, representing a substantial 29% increase. This upgraded outlook from a respected financial services company has sparked renewed confidence among investors, driving the stock's impressive intraday gains.</p>\n\n<p>While the specific reasons behind Stifel's more optimistic view weren't immediately clear, such upgrades often reflect an analyst's belief in a company's improved growth prospects or competitive position. For Indivior, this could potentially signal positive expectations regarding its product pipeline, market expansion efforts, or financial performance. As always, investors are advised to conduct their own research and consider multiple factors when making investment decisions.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Indivior Soars 5% as Stifel Boosts Price Target by 29%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Indivior Soars 5% as Stifel Boosts Price Target by 29%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-04 00:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Indivior PLC (INDV) are soaring in Monday's trading session, climbing 5.01% as investors react to a significant analyst upgrade. The pharmaceutical company, known for its focus on addiction treatment, is seeing heightened interest following a bullish stance from a major financial firm.</p>\n\n<p>The catalyst for today's upward movement appears to be Stifel's decision to raise its target price for Indivior from $28 to $36, representing a substantial 29% increase. This upgraded outlook from a respected financial services company has sparked renewed confidence among investors, driving the stock's impressive intraday gains.</p>\n\n<p>While the specific reasons behind Stifel's more optimistic view weren't immediately clear, such upgrades often reflect an analyst's belief in a company's improved growth prospects or competitive position. For Indivior, this could potentially signal positive expectations regarding its product pipeline, market expansion efforts, or financial performance. As always, investors are advised to conduct their own research and consider multiple factors when making investment decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"INDV","symbol_name":"INDIVIOR PLC","start_time":0,"source_url":"","article_id":"1194116399","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194116399","pubTimestamp":1762186222,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Indivior PLC (INDV) are soaring in Monday's trading session, climbing 5.01% as investors react to a significant analyst upgrade. The pharmaceutical company, known for its focus on addiction...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"INDV":"INDIVIOR PLC"},"translate_title":"股票追踪|Stifel将目标价上调29%，Indivior飙升5%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"INDV":1},"content_text":"Shares of Indivior PLC (INDV) are soaring in Monday's trading session, climbing 5.01% as investors react to a significant analyst upgrade. The pharmaceutical company, known for its focus on addiction treatment, is seeing heightened interest following a bullish stance from a major financial firm.\nThe catalyst for today's upward movement appears to be Stifel's decision to raise its target price for Indivior from $28 to $36, representing a substantial 29% increase. This upgraded outlook from a respected financial services company has sparked renewed confidence among investors, driving the stock's impressive intraday gains.\nWhile the specific reasons behind Stifel's more optimistic view weren't immediately clear, such upgrades often reflect an analyst's belief in a company's improved growth prospects or competitive position. For Indivior, this could potentially signal positive expectations regarding its product pipeline, market expansion efforts, or financial performance. As always, investors are advised to conduct their own research and consider multiple factors when making investment decisions.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}